Healthcare Immunotherapy Drug Market | Page 2

The global immunotherapy drug market is segmented into drug types such as
antibodies, interleukins, interferon, checkpoint inhibitors and vaccines. Among
these segments, antibodies segment is expected to occupy top position in overall
immunotherapy drug market during the forecast period. Rising usage of
antibodies in cancer treatment is impelling the growth of antibodies
immunotherapy drug market. Furthermore, increasing research & development
investment and introduction of new antibodies such as monoclonal antibodies is
anticipated to impel the growth of this segment.
Global immunotherapy drug market is expected to flourish at a CAGR of 13.0%
during the forecast period. Moreover, the global immunotherapy drug market is
expected to garner noteworthy revenue by the end of 2021. Factors such as rising
prevalence of cancer, enhancement in healthcare infrastructure and rising
disposable income are expected to significantly impact the growth of the global
immunotherapy drug market.
North America captured largest market share of immunotherapy drug in 2015.
Further, North America is projected to continue its dominance over the forecast
period. This can be attributed to the high number cancer patients in the region.
According to Center for Disease Prevention and Control, number of new cases of
cancer is anticipated to increase to 2 million per year by 2020 which further is
likely to substantially raise the demand for immunotherapy drugs. Apart from
this, favorable government initiatives are expected to impel the growth of
immunotherapy drug market in North America. Asia Pacific is expected to
showcase lucrative growth in immunotherapy drugs market during the forecast
period. Increasing prevalence of cancer and government policies and programs to
reduce the number of deaths from cancer are expected to fuel the growth of
immunotherapy drug market in Asia Pacific region.
Increased Prevalence of Cancer
Increasing number of new cases of cancer is major factor behind the growth of
immunotherapy drug market. As per the World Health Organization, new cases
of cancer are projected to increase by 70% by 2037. Consequently, the demand
for immunotherapy drugs is also expected to increase during the forecast period.
Request For Sample Pages: https://www.researchnester.com/sample-
request/2/rep-id-60
Innovation and Development of New Drugs
Copyright © Research Nester
www.researchnester.com